Month: August 2016

Phase IIB Clinical Trial of Voclosporin Successfully Achieves Primary Endpoint Good news posted yesterday on the Lupus Foundation of America website. To see the full article please click here. “(Washington DC – August 15)  Today Aurinia Pharmaceutical Company announced positive top-line results of a Phase IIB clinical study of voclosporin, a potential new therapy option for […]

EPF launches its survey on Access to Healthcare. This is a project that LUPUS EUROPE has been actively involved in as a participant in the Access to Healthcare work group at EPF. Designed by patients and patient representatives, EPF launches a unique survey on access to healthcare. Share your experience on access and help us […]